The Zenitaka Corporation (1811) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Jul, 2026Executive summary
Revenue for the nine months ended December 31, 2024, was ¥82,696 million, down 1.0% year-over-year, with construction contributing ¥80,866 million and real estate ¥1,829 million.
Operating income rose 0.8% year-over-year to ¥1,626 million, while ordinary income increased 0.9% to ¥3,094 million.
Net income attributable to shareholders fell 29.5% year-over-year to ¥2,210 million.
Financial highlights
Gross profit increased to ¥6,453 million from ¥6,193 million year-over-year.
Operating margin remained stable, with operating income at ¥1,626 million.
Comprehensive income dropped sharply to ¥2,808 million, down 70.8% year-over-year.
Total assets decreased by 4.1% from the previous fiscal year-end to ¥195,312 million.
Net assets increased by 2.3% to ¥95,021 million, with an equity ratio of 48.7%.
Outlook and guidance
Full-year revenue forecast revised to ¥120,100 million, a 0.7% decrease from the previous year.
Operating income forecast raised to ¥1,900 million (up 42.8%), ordinary income to ¥3,300 million (up 33.8%), and net income to ¥2,200 million (up 19.6%).
Dividend forecast maintained at ¥100 per share for both interim and year-end.
Latest events from The Zenitaka Corporation
- Q1 FY2025 saw steep declines in profit and revenue, but full-year guidance is unchanged.1811
Q1 202513 Jul 2026 - Interim net income fell 48% and orders dropped 40.7%, with full-year guidance unchanged.1811
Q2 202513 Jul 2026 - Net income surged 28% on stable revenue, but profit is forecast to drop next year amid rising costs.1811
Q4 202513 Jul 2026 - Strong revenue and profit growth led to an upward revision of full-year guidance.1811
Q2 202613 Jul 2026 - Q1 FY2026 saw revenue and net income soar, driven by robust construction demand.1811
Q1 202613 Jul 2026 - Strong profit growth and improved equity ratio, but cost pressures persist.1811
Q3 202613 Jul 2026 - Profits rose on higher sales and securities gains, but orders and next-year outlook are weak.1811
Q4 202613 Jul 2026